EUVIMEDEUVIMED entdecken
Randomisierte kontrollierte StudieMultizentrische StudieVergleichsstudieOpen Access · CC BY 4.0

A randomized clinical study comparing trabectedin combined with regional hyperthermia with trabectedin in patients with advanced soft tissue sarcoma: HyperTET, a German Interdisciplinary Sarcoma Group trial

G-E Schuebbe, Y Xu, L H Lindner, D Di Gioia, S Abdel-Rahman, W G Kunz, T Roshchyna, R Fenderle, V Bücklein, P Reichardt, D Pink, A Flörcken und 6 weitere

ESMO Open · 2026-04 · 11 (4) · 106921

DOI: 10.1016/j.esmoop.2026.106921 ↗

Kurz gefasst

Randomisierte kontrollierte Studie in der Zeitschrift ESMO Open, 2026-04. Verfasst von G-E Schuebbe und 17 weiteren Autor:innen. Beteiligte Einrichtung: Department of Medicine III, University Hospital, LMU Munich, Munich, Germany. Electronic address: gesa.schuebbe@med.uni-muenchen.de. Hauptthemen laut MEDLINE: Antineoplastic Agents, Alkylating, Hyperthermia, Induced, Sarcoma, Trabectedin. Die Arbeit nennt 29 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: PharmaMar SA.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Kein Abstract verfügbar.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Antineoplastic Agents, AlkylatingHyperthermia, InducedSarcomaTrabectedinAdultAgedFemaleHumansMaleMiddle AgedCombined Modality TherapyGermanyProgression-Free Survival

Stichwörter der Autor:innen

number of cycle dependencyrandomized trialregional hyperthermiaregional hyperthermia as tumor-targeting therapysoft tissue sarcomatrabectedin

Substanzen

Antineoplastic Agents, AlkylatingTrabectedin

Autor:innen und Institutionen

  • Department of Medicine III, University Hospital, LMU Munich, Munich, Germany. Electronic address: gesa.schuebbe@med.uni-muenchen.de.
  • Institute of Medical Informatics, Biometry, and Epidemiology, LMU Munich, Munich, Germany.
  • Department of Medicine III, University Hospital, LMU Munich, Munich, Germany.
  • Department of Radiology, University Hospital, LMU Munich, Munich, Germany.
  • Helios Klinikum Berlin-Buch, Berlin, Germany.
  • Department of Haematology, Oncology, HELIOS Klinikum Bad Saarow, Bad Saarow, Germany; Klinik für Innere Medizin C der Universitätsmedizin Greifswald, Greifswald, Germany.

Förderung

  • PharmaMar SA

Zitieren

APA

Schuebbe, G. E., Xu, Y., Lindner, L. H., Di Gioia, D., Abdel-Rahman, S., Kunz, W. G., Roshchyna, T., Fenderle, R., Bücklein, V., Reichardt, P., Pink, D., Flörcken, A., Ott, O., Fietkau, R., Kampmann, E., von Bergwelt-Baildon, M., Kasper, B., & Issels, R. (2026). A randomized clinical study comparing trabectedin combined with regional hyperthermia with trabectedin in patients with advanced soft tissue sarcoma: HyperTET, a German Interdisciplinary Sarcoma Group trial. ESMO Open, 11(4), 106921. https://doi.org/10.1016/j.esmoop.2026.106921

Vancouver

Schuebbe GE, Xu Y, Lindner LH, Di Gioia D, Abdel-Rahman S, Kunz WG, et al. A randomized clinical study comparing trabectedin combined with regional hyperthermia with trabectedin in patients with advanced soft tissue sarcoma: HyperTET, a German Interdisciplinary Sarcoma Group trial. ESMO Open. 2026;11(4):106921. doi:10.1016/j.esmoop.2026.106921

BibTeX
@article{Schuebbe2026,
  author = {Schuebbe, G-E and Xu, Y and Lindner, L H and Di Gioia, D and Abdel-Rahman, S and Kunz, W G and Roshchyna, T and Fenderle, R and Bücklein, V and Reichardt, P and Pink, D and Flörcken, A and Ott, O and Fietkau, R and Kampmann, E and von Bergwelt-Baildon, M and Kasper, B and Issels, R},
  title = {A randomized clinical study comparing trabectedin combined with regional hyperthermia with trabectedin in patients with advanced soft tissue sarcoma: HyperTET, a German Interdisciplinary Sarcoma Group trial},
  journal = {ESMO Open},
  year = {2026},
  volume = {11},
  number = {4},
  pages = {106921},
  doi = {10.1016/j.esmoop.2026.106921}
}
Kostenlos starten →